Nippon Soda Co. and Hokkaido University Initiate Collaborative Research
In an ambitious venture aiming to merge veterinary and human medicine, Nippon Soda Co., Ltd. has announced a collaborative research project with the Institute for Vaccine Research and Development (IVReD) and the Graduate School of Veterinary Medicine at Hokkaido University. This partnership, set to commence on March 13, 2026, aims to develop innovative animal pharmaceuticals and establish commercial manufacturing methods, ultimately bridging the gap between animal and human medicine through the concept of Zoobiquity.
Understanding Zoobiquity
Zoobiquity is an influential approach that integrates human and veterinary medicine, allowing for the exploration of common diseases, behaviors, and physiological phenomena across species. Introduced in 2012 by American cardiologist Barbara Natterson-Horowitz, this concept is increasingly gaining recognition as a tool for advancing medical knowledge and treatments that could benefit both animals and humans.
Objectives of the Collaborative Research
The core goals of this joint research include:
1.
Development of New Animal Pharmaceuticals: Using the expertise accumulated by the Graduate School of Veterinary Medicine, Nippon Soda aims to design novel medications that can meet the needs of veterinary care.
2.
Establishment of Commercial Manufacturing Methods: This project will work towards creating efficient production processes for these new pharmaceuticals, ensuring they can be brought to market effectively.
3.
Clinical Trials and Safety Testing: The research will involve conducting safety tests and clinical studies at the Hokkaido University Animal Medical Center and other veterinary facilities, focusing on both the efficacy and safety of the antibodies developed.
The duration of the collaboration extends until March 31, 2027, during which these ambitious goals are to be met through rigorous research and development.
About Nippon Soda Co., Ltd.
Founded in 1920, Nippon Soda has built a reputation for its unique technologies and expertise, providing high-value chemical products such as pesticides, pharmaceuticals, and specialty chemicals. The company is committed to responsible care in the handling of chemical substances, actively considering environmental impact, safety, quality, and health in its operations. Nippon Soda strives to create new value through innovative technologies and products, contributing to the development of a prosperous society.
For more on Nippon Soda Co., Ltd., visit
Nippon Soda.